+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Angiography Devices Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5780663
The market growth is being driven by factors such as an increase in the prevalence of cardiovascular diseases and the technological advancements in imaging modalities.

Angiography Devices Market: Introduction

The global angiography devices market refers to the market for medical devices used to perform angiography, which is a medical imaging technique used to visualize blood vessels in the body, including arteries and veins. Angiography devices are primarily used for the diagnosis and treatment of cardiovascular diseases. The market is being driven by factors such as an increase in the prevalence of cardiovascular diseases, technological advancements in imaging modalities, and the rise in the geriatric population.

Moreover, technological advancements in imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are further propelling the growth of the angiography devices market. These advancements have led to the development of more precise and accurate imaging techniques, which have enhanced the diagnosis and treatment of cardiovascular diseases.

Angiography Devices Market - Application and Usage

The angiography devices market is primarily used for the diagnosis and treatment of cardiovascular diseases. Angiography devices are used to perform angiography, a medical imaging technique used to visualize blood vessels in the body, including arteries and veins. This imaging technique is used to diagnose a variety of cardiovascular conditions, including blockages in the arteries, aneurysms, and malformations of the blood vessels.

Angiography devices are also used in the treatment of cardiovascular diseases. For example, in the case of coronary artery disease, angiography can help identify blockages in the coronary arteries, which can then be treated using percutaneous coronary intervention (PCI) or coronary artery bypass surgery.

Moreover, angiography devices can also be used in the treatment of peripheral arterial disease (PAD), which is a condition where the arteries in the arms and legs become narrow or blocked, leading to reduced blood flow to these areas. Angiography can help identify the location and severity of the blockage, which can then be treated using techniques such as angioplasty or stent placement.

In addition to these applications, angiography devices can also be used in the diagnosis and treatment of other conditions, such as kidney disease and tumors, where the blood vessels play a significant role. Overall, angiography devices play a crucial role in the diagnosis and treatment of a variety of cardiovascular and other medical conditions.

Angiography Devices Market Segmentations

The market can be categorised into product, indication, application, and distribution channel.

Market Breakup by Product

  • Angiography Systems
  • Balloons
  • Catheters
  • Contrast Media
  • Guidewire
  • Vascular Closure Devices
  • Angiography Accessories
  • Others

Market Breakup by Indication

  • Cerebral
  • Carotid
  • Peripheral
  • Aortic
  • Coronary
  • Others

Market Breakup by Application

  • Diagnostics
  • X-Rays
  • Computed Tomography (CT)
  • Magnetic Resonance Angiography (MRA)
  • Therapeutics
  • Coronary Angiography
  • Micro Angiography

Non-Coronary Angiography

  • Neurovascular Angiography
  • Peripheral Angiography
  • Others

Market Breakup by Distribution Channels

  • Hospitals
  • Diagnostic Centres
  • Research Laboratories

Angiography Devices Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Angiography Devices Market Scenario

The global angiography devices market is expected to witness significant growth in the coming years. The market is being driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements in imaging modalities, and the rise in the geriatric population.

North America dominated the global angiography devices market in 2020, followed by Europe and the Asia Pacific. The high prevalence of cardiovascular diseases, favourable reimbursement policies, and the presence of many key players in the region are driving the growth of the market in North America and Europe.

The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of cardiovascular diseases and the rising healthcare expenditure in the region. Moreover, the growing demand for minimally invasive procedures, advancements in healthcare infrastructure, and increasing investments in research and development activities are expected to fuel the growth of the angiography devices market in the Asia Pacific region.

Key Players in the Global Angiography Devices Market

The report gives an in-depth analysis of the key players involved in the angiography devices market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Siemens AG
  • Canon Medical Systems Corporation
  • Medtronic plc
  • Koninklijke Philips N.V
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Abbott Laboratories
  • Cook Group Incorporated
  • General Electric Company
  • Shimadzu Corporation
  • St. Jude Medical
  • B. Braun Melsungen AG
  • GE Healthcare
  • Cardinal Health, Inc

Table of Contents

1 Preface
1.1 Objectives of the Study
1.1.1 Research Objectives
1.1.2 Key Findings of the Report
1.2 Limitations of the Study and Scope for Future Research
2 Research Methodology3 Executive Summary
4 Global Angiography Devices Market
4.1 Global Angiography Devices Market Overview
4.2 Global Angiography Devices Market Analysis
4.2.1 Market Overview
4.2.1.1 Global Angiography Devices Market Historical Value (2016-2022)
4.2.1.2 Global Angiography Devices Market Forecast Value (2023-2031)
4.3 Global Angiography Devices Market by Product
4.3.1 Market Overview
4.3.1.1 Angiography Systems
4.3.1.2 Balloons
4.3.1.3 Catheters
4.3.1.4 Contrast Media
4.3.1.5 Guidewire
4.3.1.6 Vascular Closure Devices
4.3.1.7 Angiography Accessories
4.3.1.8 Others
4.4 Global Angiography Devices Market by Indication
4.4.1 Market Overview
4.4.1.1 Cerebral
4.4.1.2 Carotid
4.4.1.3 Peripheral
4.4.1.4 Aortic
4.4.1.5 Coronary
4.4.1.6 Others
4.5 Global Angiography Devices Market by Application
4.5.1 Market Overview
4.5.1.1 Diagnostics
4.5.1.1.1 X-Rays
4.5.1.1.2 Computed Tomography (CT)
4.5.1.1.3 Magnetic Resonance Angiography (MRA)
4.5.1.2 Therapeutics
4.5.1.2.1 Coronary Angiography
4.5.1.2.2 Micro Angiography
4.5.1.2.3 Non-Coronary Angiography
4.5.1.2.3.1 Neurovascular Angiography
4.5.1.2.3.2 Peripheral Angiography
4.5.1.3 Others
4.6 Global Angiography Devices Market by Distribution Channels
4.6.1 Market Overview
4.6.1.1 Hospitals
4.6.1.2 Diagnostic Centers
4.6.1.3 Research Laboratories
4.7 Global Angiography Devices Market by Region
4.7.1 Market Overview
4.7.1.1 North America
4.7.1.2 Europe
4.7.1.3 Asia Pacific
4.7.1.4 Latin America
4.7.1.5 Middle East and Africa
4.7.2 North America
4.7.2.1 Historical Trend (2016-2022)
4.7.2.2 Forecast Trend (2023-2031)
4.7.2.3 Break Up by Country
4.7.2.3.1 United States of America
4.7.2.3.2 Canada
4.7.3 Europe
4.7.3.1 Historical Trend (2016-2022)
4.7.3.2 Forecast Trend (2023-2031)
4.7.3.3 Break Up by Country
4.7.3.3.1 United Kingdom
4.7.3.3.2 Germany
4.7.3.3.3 France
4.7.3.3.4 Italy
4.7.3.3.5 Others
4.7.4 Asia Pacific
4.7.4.1 Historical Trend (2016-2022)
4.7.4.2 Forecast Trend (2023-2031)
4.7.4.3 Break Up by Country
4.7.4.3.1 China
4.7.4.3.2 Japan
4.7.4.3.3 India
4.7.4.3.4 ASEAN
4.7.4.3.5 Australia
4.7.4.3.6 Others
4.7.5 Latin America
4.7.5.1 Historical Trend (2016-2022)
4.7.5.2 Forecast Trend (2023-2031)
4.7.5.3 Break Up by Country
4.7.5.3.1 Brazil
4.7.5.3.2 Argentina
4.7.5.3.3 Mexico
4.7.5.3.4 Others
4.7.6 Middle East and Africa
4.7.6.1 Historical Trend (2016-2022)
4.7.6.2 Forecast Trend (2023-2031)
4.7.6.3 Break Up by Country
4.7.6.3.1 Saudi Arabia
4.7.6.3.2 United Arab Emirates
4.7.6.3.3 Nigeria
4.7.6.3.4 South Africa
4.7.6.3.5 Others
5 Trade Data Analysis by HS Code
5.1 Angiography Diagnostic System- 90189019
5.2 Cardiac and Vascular Angiography System - 90189099
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials Synopsis
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Device Development to Commercial Launch
6.2.1.3 New Device Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Global Angiography Devices Market Dynamics
7.1 Market Drivers and Constraints
7.2 SWOT Analysis
7.3 Porter’s Five Forces Model
7.4 Key Demand Indicators
7.5 Key Price Indicators
7.6 Industry Events, Initiatives, and Trends
7.7 Value Chain Analysis
8 Supplier Landscape
8.1 Siemens AG
8.1.1 Company Overview
8.1.2 Product Portfolio
8.1.3 Demographic Reach and Achievements
8.1.4 Mergers and Acquisitions
8.1.5 Certifications
8.2 Canon Medical Systems Corporation
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Demographic Reach and Achievements
8.2.4 Mergers and Acquisitions
8.2.5 Certifications
8.3 Medtronic plc
8.3.1 Company Overview
8.3.2 Product Portfolio
8.3.3 Demographic Reach and Achievements
8.3.4 Mergers and Acquisitions
8.3.5 Certifications
8.4 Koninklijke Philips N.V.
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Demographic Reach and Achievements
8.4.4 Mergers and Acquisitions
8.4.5 Certifications
8.5 Boston Scientific Corporation
8.5.1 Company Overview
8.5.2 Product Portfolio
8.5.3 Demographic Reach and Achievements
8.5.4 Mergers and Acquisitions
8.5.5 Certifications
8.6 Johnson & Johnson
8.6.1 Company Overview
8.6.2 Product Portfolio
8.6.3 Demographic Reach and Achievements
8.6.4 Mergers and Acquisitions
8.6.5 Certifications
8.7 Abbott Laboratories
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Demographic Reach and Achievements
8.7.4 Mergers and Acquisitions
8.7.5 Certifications
8.8 Cook Group Incorporated
8.8.1 Company Overview
8.8.2 Product Portfolio
8.8.3 Demographic Reach and Achievements
8.8.4 Mergers and Acquisitions
8.8.5 Certifications
8.9 General Electric Company
8.9.1 Company Overview
8.9.2 Product Portfolio
8.9.3 Demographic Reach and Achievements
8.9.4 Mergers and Acquisitions
8.9.5 Certifications
8.10 Shimadzu Corporation
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Demographic Reach and Achievements
8.10.4 Mergers and Acquisitions
8.10.5 Certifications
8.11 St. Jude Medical
8.11.1 Company Overview
8.11.2 Product Portfolio
8.11.3 Demographic Reach and Achievements
8.11.4 Mergers and Acquisitions
8.11.5 Certifications
8.12 B. Braun Melsungen AG
8.12.1 Company Overview
8.12.2 Product Portfolio
8.12.3 Demographic Reach and Achievements
8.12.4 Mergers and Acquisitions
8.12.5 Certifications
8.13 GE Healthcare
8.13.1 Company Overview
8.13.2 Product Portfolio
8.13.3 Demographic Reach and Achievements
8.13.4 Mergers and Acquisitions
8.13.5 Certifications
8.14 Cardinal Health, Inc.
8.14.1 Company Overview
8.14.2 Product Portfolio
8.14.3 Demographic Reach and Achievements
8.14.4 Mergers and Acquisitions
8.14.5 Certifications
9 Recommendations and Discussion
10 Pricing Models and Strategies (Additional Insight)
10.1 Overview
10.2 Cost Model
10.2.1 Manufacturing Cost Analysis
10.2.2 Procurement Cost Analysis
10.2.3 Clinical Trial Cost Factors
10.3 Pricing Strategies
10.3.1 Competitor Pricing Analysis
10.3.2 Key Assessment of Product Attributes
10.3.3 Pricing Benchmark
11 Global Angiography Devices Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment

Companies Mentioned

  • Siemens AG
  • Canon Medical Systems Corporation
  • Medtronic plc
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Abbott Laboratories
  • Cook Group Incorporated
  • General Electric Company
  • Shimadzu Corporation
  • St. Jude Medical
  • B. Braun Melsungen AG
  • GE Healthcare
  • Cardinal Health, Inc.

Methodology

Loading
LOADING...